WARF ADVANCES
Top licensing prospects from the University of Wisconsin-Madison
Reducing the Rate of Type 1 Diabetes
Molecules that modify insulin to prevent the immune system from recognizing the protein as foreign can be given as dietary supplements to infants at a time when the immune system is developing rapidly.
Read more
Implantable Pressure Sensing Device to Monitor Intracranial Pressure
UW-Madison researchers have designed a minimally invasive, mechanical sensing device for intracranial pressure (ICP) that can be implanted during neurosurgery for long-term ICP monitoring.
Read more
Predicting Cell-Surface Protein Expression
This web-based atlas of cell surface target protein expression across various cancer types can be used to identify understudied drug targets for therapeutic development, select patients for clinical trials or guide treatment decisions.
Read more
Forward Programmed Blood-Brain Barrier Models
UW-Madison researchers have developed a method for differentiating human pluripotent stem cells into endothelial cells that results in a model with key blood-brain barrier properties.
Read more
Dietary Tripropionin to Reduce Adiposity and Improve Glucose Homeostasis
This method of supplementing with tripropionin, a triglyceride containing three propionate fatty acids tails, reduces adiposity and promotes glucose homeostasis.
Read more
Flexible Modular Phantom Using Interchangeable Inserts
UW-Madison researchers have developed a phantom for radiation treatment planning and medical imaging that allows for simulating organ motion typically seen in patients.
Read more
Read about more licensing prospects!
Featured UW-Madison Researcher
 |
Wei Xu, Professor of Oncology
“Prof. Xu is an expert in breast cancer biology. We are excited about the novel targets and mechanisms coming from her research.” – Rafael Diaz, WARF Licensing Manager |
In the News